A study conducted out by Cancer Research UK has discovered that carrying out one-off PSA tests on asymptomatic men does not reduce prostate cancer deaths.
Browsing: Disease Area > Prostate
Three hospitals in the UK are trialing a ‘one-stop’ prostate cancer diagnosis service, which is expected to reduce the time taken for a diagnosis from approximately 6 weeks to just days.
Researchers have successfully utilized a novel metal detection technique for mapping and tracking breakaway cancerous cells.
Data recently released from Prostate Cancer UK demonstrates that prostate cancer has become the third most common cause of cancer death in the UK, overtaking breast cancer.
Researchers have discovered that a shorter course of radiation using higher doses over fewer days may be a more effective approach for some men with intermediate-risk prostate cancer.
Prostate cancer screening and detection remain challenging issues, with changes in recommendations for prostate-specific antigen testing causing a significant change in approach. In this editorial discover the multiple roles and applications of prostate MRI.
Discover the promises and limitations of peptide-based vaccines for the treatment of prostate cancer, in this commentary article from Future Science OA
This review discusses the key sequences that comprise a mpMRI exam of the prostate gland including technical factors that affect image quality, such as pre-exam patient preparation, magnet field strength, endorectal coil utilization and sequence parameters.